Dual orexin receptor antagonist ameliorates sleep deprivation-induced learning and memory impairment in APP/PS1 mice
Sleep Medicine · 2024-09 · 121 · 303-314
DOI: 10.1016/j.sleep.2024.07.023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep Medicine, 2024-09. Verfasst von Yaran Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Shandong First Medical University, China. Hauptthemen laut MEDLINE: Sleep Deprivation, Orexin Receptor Antagonists, Alzheimer Disease, Disease Models, Animal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jinan Science and Technology Bureau, Taishan Scholar Project of Shandong Province.
Abstract (Originalsprache)
Sleep is considered closely related to cognitive function, and cognitive impairment is the main clinical manifestation of Alzheimer's disease (AD). Sleep disturbance in AD patients is more severe than that in healthy elderly individuals. Additionally, sleep deprivation reportedly increases the activity of the hypothalamic orexin system and the risk of AD. To investigate whether intervention with the orexin system can improve sleep disturbance in AD and its impact on AD pathology. In this study, six-month-old amyloid precursor protein/presenilin 1 mice were subjected to six weeks of chronic sleep deprivation and injected intraperitoneally with almorexant, a dual orexin receptor antagonist (DORA), to investigate the effects and mechanisms of sleep deprivation and almorexant intervention on learning and memory in mice with AD. We found that sleep deprivation aggravated learning and memory impairment and increased brain β-amyloid (Aβ) deposition in mice with AD. The application of almorexant can increase the total sleep time of sleep-deprived mice and reduce cognitive impairment and Aβ deposition, which is related to the improvement in Aquaporin-4 polarity. Thus, DORA may be an effective strategy for delaying the progression of AD patients by improving the sleep disturbances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Shandong First Medical University, China.
- Department of Neurology, Shandong Provincial Qian Foshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
- Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China; Department of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong,…
Förderung
- National Natural Science Foundation of China
- Jinan Science and Technology Bureau
- Taishan Scholar Project of Shandong Province
- Natural Science Foundation of Shandong Province
- China Postdoctoral Science Foundation
Zitieren
APA
Li, Y., Yan, Z., Shao, N., Tang, S., Zhang, X., Liu, X. M., & Tang, J. (2024). Dual orexin receptor antagonist ameliorates sleep deprivation-induced learning and memory impairment in APP/PS1 mice. Sleep Medicine, 121, 303-314. https://doi.org/10.1016/j.sleep.2024.07.023
Vancouver
Li Y, Yan Z, Shao N, Tang S, Zhang X, Liu XM, et al. Dual orexin receptor antagonist ameliorates sleep deprivation-induced learning and memory impairment in APP/PS1 mice. Sleep Medicine. 2024;121:303-314. doi:10.1016/j.sleep.2024.07.023
BibTeX
@article{Li2024,
author = {Li, Yaran and Yan, Zian and Shao, Na and Tang, Shi and Zhang, Xiao and Liu, Xiao Min and Tang, Jiyou},
title = {Dual orexin receptor antagonist ameliorates sleep deprivation-induced learning and memory impairment in APP/PS1 mice},
journal = {Sleep Medicine},
year = {2024},
volume = {121},
pages = {303--314},
doi = {10.1016/j.sleep.2024.07.023}
}
EUVIMED